MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
835.61%
Quick Ratio
835.61%
Cash Ratio
329.67%
Debt to Asset Ratio
10.51%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Cash and cash equivalents
Fixed assets, net
Others
Liabilities Breakdown
Accumulated deficit
Redeemable noncontrolling intere...
Additionalpaid-incapital
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
74,868
101,895
108,537
95,323
Marketable securities
106,696
123,049
161,480
176,402
Interest receivable
956
1,032
1,127
1,237
Prepaid assets
2,827
3,083
2,808
3,516
Prepaid clinical
3,649
4,049
3,923
4,351
Assets held for sale
-
-
0
19,050
Other current assets
772
1,794
2,804
110
Total current assets
189,768
234,902
280,679
299,989
Fixed assets, net
56,037
54,441
51,231
47,754
Right of use assets, net
3,211
3,441
3,664
3,865
Total assets
249,016
292,784
335,574
351,608
Accounts payable
1,610
2,592
940
1,942
Lease liabilities
1,129
1,108
1,071
991
Accrued expenses and other
19,971
22,231
28,731
26,068
Income taxes payable
-
0
0
62
Total current liabilities
22,710
25,931
30,742
29,063
Income tax payable, net of current portion
1,074
1,074
1,074
962
Lease liabilities, net of current portion
2,394
2,675
2,965
3,245
Total liabilities
26,178
29,680
34,781
33,270
Redeemable noncontrolling interest
1,106,370
1,286,887
1,311,990
1,326,358
Common stock value-Common Class A
21
14
14
14
Common stock value-Common Class B
10
16
16
16
Additionalpaid-incapital
434,765
266,112
258,552
242,480
Accumulated other comprehensive (loss) gain
-34
-53
56
74
Accumulated deficit
-1,318,294
-1,289,872
-1,269,835
-1,250,604
Total stockholders' deficit
-883,532
-1,023,783
-1,011,197
-1,008,020
Total liabilities and shareholders' deficit
249,016
292,784
335,574
351,608
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$106,696K
(-49.14%↓ Y/Y)
Cash and cash
equivalents
$74,868K
(-11.86%↓ Y/Y)
Prepaid clinical
$3,649K
(-36.24%↓ Y/Y)
Prepaid assets
$2,827K
(22.91%↑ Y/Y)
Interest receivable
$956K
(-46.14%↓ Y/Y)
Other current assets
$772K
(41.39%↑ Y/Y)
Total current assets
$189,768K
(-41.51%↓ Y/Y)
Fixed assets, net
$56,037K
(28.75%↑ Y/Y)
Right of use assets,
net
$3,211K
(-22.96%↓ Y/Y)
Total assets
$249,016K
(-33.08%↓ Y/Y)
Accumulated deficit
-$1,318,294K
(-6.82%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$34K
(-213.33%↓ Y/Y)
Total liabilities and
shareholders' deficit
$249,016K
(-33.08%↓ Y/Y)
Total stockholders'
deficit
-$883,532K
(11.87%↑ Y/Y)
Additionalpaid-incapital
$434,765K
(87.74%↑ Y/Y)
Common stock
value-Common Class A
$21K
(61.54%↑ Y/Y)
Common stock
value-Common Class B
$10K
(-37.50%↓ Y/Y)
Redeemable noncontrolling
interest
$1,106,370K
(-17.56%↓ Y/Y)
Total liabilities
$26,178K
(-19.90%↓ Y/Y)
Total current
liabilities
$22,710K
(-19.64%↓ Y/Y)
Lease liabilities,
net of current...
$2,394K
(-31.89%↓ Y/Y)
Income tax payable, net
of current portion
$1,074K
(18.94%↑ Y/Y)
Accrued expenses and
other
$19,971K
(-19.85%↓ Y/Y)
Accounts payable
$1,610K
(-34.10%↓ Y/Y)
Lease liabilities
$1,129K
(25.03%↑ Y/Y)
Buy us a coffee
PROKIDNEY CORP. (PROK)
PROKIDNEY CORP. (PROK)